MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
and redemptions of...
$48,000K
Proceeds from stock
option exercises
$623K
Net cash (used in)
provided by investing...
$21,839K
Net cash provided by
financing activities
$623K
Canceled cashflow
$26,161K
Net increase
(decrease) in cash, cash...
-$1,370K
Canceled cashflow
$22,462K
Stock-based compensation
expense
$5,406K
Accounts receivable
-$1,368K
Prepaid expenses and
other current assets
-$951K
Depreciation expense
$585K
Amortization of operating
lease right-of-use...
$402K
Deferred revenue
$201K
Amortization of premium
(discount) on short-term...
$86K
Other long-term
liabilities
$11K
Purchases of long-term
investments
$24,784K
Purchases of property and
equipment
$1,377K
Net cash used in
operating activities
-$23,832K
Canceled cashflow
$9,010K
Net loss
-$21,895K
Accrued expenses and
other current...
-$5,217K
Accounts payable
-$3,333K
Inventories
$1,803K
Operating lease liability
-$391K
Net provision
(recovery) for excess and...
-$202K
Other long-term
assets
$1K
Back
Back
Cash Flow
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)
source: myfinsight.com